From the publishers of JADPRO

Gastrointestinal Stromal Tumor Resource Center

Advertisement

JADPRO

Management of patients with advanced gastrointestinal stromal tumor: Emphasis on fourth-line treatment with ripretinib

Future Oncology

The INSIGHT study: A randomized, phase III study of ripretinib versus sunitinib for advanced gastrointestinal stromal tumor with KIT exon 11 + 17/18 mutations

Cureus

Optimizing outcomes in gastrointestinal stromal tumors: A surgeon's perspective

Chinese Journal of Gastrointestinal Surgery

Analysis of the efficacy of adjusting the dose of imatinib with therapeutic drug monitoring in adjuvant treatment after complete resection of gastrointestinal stromal tumors

BJC Reports

Different efficacy of tyrosine kinase inhibitors by KIT and PGFRA mutations identified in circulating tumor DNA for the treatment of refractory gastrointestinal stromal tumors

Journal of Cancer Research and Clinical Oncology

Overall survival of patients with KIT-mutant metastatic GIST in the era of multiple kinase inhibitor availability

Journal of Cancer Research and Clinical Oncology

Current drug resistance mechanisms and treatment options in gastrointestinal stromal tumors: Summary and update

Advances in Anatomic Pathology

Gastrointestinal stromal tumors: Variants and some pitfalls that they create

Drugs & Aging

Individualized dosing patterns in the treatment of older patients with gastrointestinal stromal tumors: Results of a registry-based observational national cohort study including 871 patients

Cureus

Neoadjuvant imatinib in gastrointestinal stromal tumors (GIST): The first analysis of a Mexican population

Oncology Letters

Clinical characteristics of gastrointestinal stromal tumors with hypoglycemia

Surgical Endoscopy

Population-based long-term prognosis analysis of subcutaneous gastrointestinal stromal tumors

Clinical Gastroenterology

Endoscopic removal of gastrointestinal lesions by using third space endoscopy techniques

Lancet Oncology

Discontinuation versus continuation of imatinib in patients with advanced gastrointestinal stromal tumours (BFR14): Exploratory long-term follow-up of an open-label, multicentre, randomised, phase 3 trial

JCO Precision Oncology

Efficacy of trametinib in neurofibromatosis type 1-associated GIST: A case report

Cancers (Basel)

Mesenchymal tumor management: Integrating surgical and non-surgical strategies in different clinical scenarios

Gastrointestinal Tract

Safety outcomes of low versus high dose imatinib mesylate in patients with advanced, metastatic, or nonresectable gastrointestinal stromal tumors: A systematic review

Journal of Clinical Medicine

Understanding gastric GIST: From pathophysiology to personalized treatment

Langenbeck's Archives of Surgery

Is laparoscopic approach as treatment of large gastric GIST acceptable?

Heliyon

The immunotherapy in gastrointestinal stromal tumors

International Journal of Molecular Sciences

Pilot study by liquid biopsy in gastrointestinal stromal tumors: Analysis of PDGFRA D842V mutation and hypermethylation of SEPT9 presence by digital droplet PCR

Frontiers in Oncology

Gastrointestinal stromal tumor with small cell carcinoma infiltration: A case report

Canadian Association of Radiologists Journal

Cinematic rendering of gastrointestinal stromal tumours: A review of current possibilities and future developments

Frontiers in Oncology

Large-scale, prospective observational study of regorafenib in Japanese patients with advanced gastrointestinal stromal tumors in a real-world clinical setting

Nature Medicine

Ripretinib versus sunitinib in gastrointestinal stromal tumor: ctDNA biomarker analysis of the phase 3 INTRIGUE trial

BMC Surgery

Short-term and long-term outcomes after robotic radical surgery for rectal gastrointestinal stromal tumor

Cancers

Utility of clinical next generation sequencing tests in KIT/PDGFRA/SDH wild-type gastrointestinal stromal tumors

The Journal of Medical Investigation: JMI

Feasibility of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor with tumor diameter of >5 cm

Biomarker Testing for Genetic Evaluation of GISTs

Treating a Patient Newly Diagnosed With GIST